Literature DB >> 7778800

[Antibiotic prophylaxis in hepatobiliary surgery].

A Chalfine1.   

Abstract

Today, hepatic and biliary surgery includes conventional biliary surgery, laparoscopic surgery, interventional radiology, endoscopy and hepatic resection surgery. In conventional biliary surgery, the benefit of antibiotic prophylaxis has been demonstrated. Among the risk factors, some are specific (age > 65 years, gallstones in the common bile duct with or without jaundice, history of acute cholecystitis or of biliary surgery) and the others are non specific such as the CDC new index risk (for scoring from 0 to 3, wound infection rates are respectively 1.36, 2.01, 7.11, 11.54%). The targets for antibiotics used in conventional biliary surgery are E. coli, Klebsiella and Streptococcus. In biliary laparoscopic surgery, the rate of infectious complications and results of antibiotic prophylaxis have not been assessed. However, in laparoscopic surgery, the use of an antibiotic prophylaxis similar to that employed in conventional biliary surgery seems logical. In interventional radiology and endoscopy, the modalities and the benefit of antibiotic prophylaxis have not yet been assessed. Infections (angio-cholecystitis) secondary to these procedures are frequent and severe. They are due to multiresistant hospital microorganisms. Antibiotic prophylaxis regimens for hepatic resections have not yet been assessed and are the same as for conventional biliary surgery.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7778800     DOI: 10.1016/s0750-7658(05)81789-7

Source DB:  PubMed          Journal:  Ann Fr Anesth Reanim        ISSN: 0750-7658


  2 in total

1.  Physiological modeling for indirect evaluation of drug tissular pharmacokinetics under non-steady-state conditions: an example of antimicrobial prophylaxis during liver surgery.

Authors:  Franck Lagneau; Jean Marty; Pascale Beyne; Michel Tod
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-02       Impact factor: 2.745

2.  Double-blind comparison of cefazolin and ceftizoxime for prophylaxis against infections following elective biliary tract surgery.

Authors:  P J Jewesson; G Stiver; A Wai; L Frighetto; D Nickoloff; J Smith; L Schwartz; K Sleigh; D Danforth; C Scudamore; A Chow
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.